Table 1.

Criteria for treatment initiation and prioritization of the Spanish national strategic plan for the diagnosis, treatment, and management of HCV infection

Prioritization criteria for implementing HCV treatment
• All patients with liver fibrosis stages F4, F3, or F2
• Patients on the waiting list for liver transplant
• Patients with liver transplant, independent of stage of liver fibrosis
• Patients with failed treatment with Peg-IFN/RBV in combination with boceprevir or telaprevir
• Patient who are recipients of non-liver transplants, independent of stage of liver fibrosis
• Patients with extra-hepatic manifestations, independent of stage of liver fibrosis
• Patients with stage F0–F2 liver fibrosis, in the following situations:
• Patients at risk of transmission
• Women wishing to become pregnant

HCV hepatitis C virus; F4 liver cirrhosis; F3 liver fibrosis stage 3; F2 liver fibrosis stage 2; F1 liver fibrosis stage 1; F0 absence of liver fibrosis; Peg-IFN/RBV pegylated interferon plus ribavirin